Evan Y. Snyder

Evan Y. Snyder

Auto-generated profile, based on publicly available information

Evan Y. Snyder

Sanford Burnham Prebys Medical Discovery Institute, La Jolla, CA 92037, USA

Research Focus & Metrics

Academic Career Length

10Years (2017-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
12 May 2017 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Closed access
PDF file
BTBrian T. D. Tobe
Brian T. D. Tobe
ACAndrew M. Crain
Andrew M. Crain
AWAlicia M. Winquist
Alicia M. Winquist
BCBarbara Calabrese
Barbara Calabrese
HMHiroko Makihara
Hiroko Makihara
ESEvan Y. Snyder
Evan Y. Snyder
Significance: One-third of bipolar disorder (BPD) patients are lithium-responsive (LiR) for unknown reasons. Were lithium’s target to be identified, then BPD’s pathogenesis might be unraveled. We identified and mapped the “lithium-response pathway,” which governs the phosphorylation of CRMP2 , a cytoskeleton regulator, particularly for dendritic spines: hence, a neural network modulator. Although “toggling” between inactive (phosphorylated) and active (nonphosphorylated) CRMP2 is physiologic, the “set-point” in LiR BPD is abnormal. Lithium (and other pathway-modulators) normalize that set-point. Hence, BPD is a disorder not of a gene but of the posttranslational regulation of a developmentally critical molecule. Such knowledge should enable better mechanistically based treatments and bioassays. Instructively, lithium was our “molecular can-opener” for “prying” intracellularly to reveal otherwise inscrutable pathophysiology in this complex polygenic disorder.

8 July 2020 in Current Protocols in Stem Cell Biology
Verified
Journal Article
Open access
PDF file
SLSandra L. Leibel
Sandra L. Leibel
RMRachael N. McVicar
Rachael N. McVicar
AWAlicia M. Winquist
Alicia M. Winquist
WNWalter D. Niles
Walter D. Niles
ESEvan Y. Snyder
Evan Y. Snyder
The normal development of the pulmonary system is critical to transitioning from placental‐dependent fetal life to alveolar‐dependent newborn life. Human lung development and disease have been difficult to study due to the lack of an in vitro model system containing cells from the large airways and distal alveolus. This article describes a system that allows human embryonic stem cells (hESCs) and induced pluripotent stem cells (hiPSCs) to differentiate and form three‐dimensional (3D) structures that emulate the development, cytoarchitecture, and function of the lung (“organoids”), containing epithelial and mesenchymal cell populations, and including the production of surfactant and presence of ciliated cells. The organoids can also be invested with mesoderm derivatives, differentiated from the same human pluripotent stem cells, such as alveolar macrophages and vasculature. Such lung organoids may be used to study the impact of environmental modifiers and perturbagens (toxins, microbial or viral pathogens, alterations in microbiome) or the efficacy and safety of drugs, biologics, and gene transfer. © 2020 Wiley Periodicals LLC.Basic Protocol: hESC/hiPSC dissection, definitive endoderm formation, and lung progenitor cell induction

20 November 2020 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
JLJean-Pyo Lee
Jean-Pyo Lee
RZRunquan Zhang
Runquan Zhang
MYMaocai Yan
Maocai Yan
SDSrinivas Duggineni
Srinivas Duggineni
DWDustin R. Wakeman
Dustin R. Wakeman
ESEvan Y. Snyder
Evan Y. Snyder
Significance: While inflammatory chemokines, constitutively produced by pathologic regions, are pivotal for attracting reparative stem cells, one would certainly not want to further “inflame” a diseased brain by instilling such molecules. Exploiting the fact that receptors for such cytokines (G protein-coupled receptors [GPCR]) possess two “pockets”—one for binding, the other for signaling—we created a synthetic GPCR-agonist that maximizes interaction with the former and narrows that with the latter. Homing is robust with no inflammation. The peptide successfully directed the integration of human induced pluripotent stem cell derivatives (known to have muted migration) in a model of a prototypical neurodegenerative condition, ameliorating symptomatology.

30 July 2021 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
PDF file
MNMunetaka Nomoto
Munetaka Nomoto
GKGlenn T. Konopaske
Glenn T. Konopaske
NYNaoya Yamashita
Naoya Yamashita
RAReina Aoki
Reina Aoki
AJAoi Jitsuki-Takahashi
Aoi Jitsuki-Takahashi
YGYoshio Goshima
Yoshio Goshima
Significance: There are no biomarkers for schizophrenia (SCZ), a disorder of dysfunctional neural networks. We demonstrate that a master regulator of cytoskeleton (“CRMP2”) and, hence, neural circuitry, may form the basis for such a biomarker because its activity is uniquely imbalanced in SCZ patients. We show that SCZ patients are characterized by an excess of active CRMP2 not only in their brains (where it is correlated with dendritic abnormalities) but also in their peripheral blood lymphocytes. The abundance of active CRMP2 and insufficiency of opposing inactive p-CRMP2 likely disrupts neuronal function. Because peripheral blood CRMP2 appears to reflect intracerebral processes, it could form the basis of a rapid, minimally invasive, sensitive, and specific clinical diagnostic aid for SCZ in young patients.

19 July 2024 in Proceedings of the National Academy of Sciences
Verified
Journal Article
Open access
SLSandra L. Leibel
Sandra L. Leibel
RMRachael N. McVicar
Rachael N. McVicar
RMRabi Murad
Rabi Murad
EKElizabeth M. Kwong
Elizabeth M. Kwong
ACAlex E. Clark
Alex E. Clark
ESEvan Y. Snyder
Evan Y. Snyder
The prevalence of “long COVID” is just one of the conundrums highlighting how little we know about the lung’s response to viral infection, particularly to syndromecoronavirus-2 (SARS-CoV-2), for which the lung is the point of entry. We used an in vitro human lung system to enable a prospective, unbiased, sequential single-cell level analysis of pulmonary cell responses to infection by multiple SARS-CoV-2 strains. Starting with human induced pluripotent stem cells and emulating lung organogenesis, we generated and infected three-dimensional, multi-cell-type-containing lung organoids (LOs) and gained several unexpected insights. First, SARS-CoV-2 tropism is much broader than previously believed: Many lung cell types are infectable, if not through a canonical receptor-mediated route (e.g., via Angiotensin-converting encyme 2(ACE2)) then via a noncanonical “backdoor” route (via macropinocytosis, a form of endocytosis). Food and Drug Administration (FDA)-approved endocytosis blockers can abrogate such entry, suggesting adjunctive therapies. Regardless of the route of entry, the virus triggers a lung-autonomous, pulmonary epithelial cell–intrinsic, innate immune response involving interferons and cytokine/chemokine production in the absence of hematopoietic derivatives. The virus can spread rapidly throughout human LOs resulting in mitochondrial apoptosis mediated by the prosurvival protein Bcl-xL. This host cytopathic response to the virus may help explain persistent inflammatory signatures in a dysfunctional pulmonary environment of long COVID. The host response to the virus is, in significant part, dependent on pulmonary Surfactant Protein-B, which plays an unanticipated role in signal transduction, viral resistance, dampening of systemic inflammatory cytokine production, and minimizing apoptosis. Exogenous surfactant, in fact, can be broadly therapeutic.

27 August 2019 in The Journal of Pediatrics
Verified
Journal Article
Closed access
PDF file
AKAnup Katheria
Anup Katheria
RARamina Amino
Ramina Amino
JKJason M. Konop
Jason M. Konop
AOAnthony J. Orona
Anthony J. Orona
EKElizabeth Kim
Elizabeth Kim
ESEvan Y. Snyder
Evan Y. Snyder